Lataa...
Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experience with brolucizumab in wet AMD) was a retrospective, observational, multice...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8268719/ https://ncbi.nlm.nih.gov/pubmed/34201729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10132758 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|